Podcasts about diagnostics

This is the final episode in a 5-part series with Chahan Yeretzian, Professor for Analytical Technologies, Bioanalytical Chemistry, and Diagnostics at Zurich University of Applied Sciences (ZHAW). In this series, Chahan and Lee explore "The Science of Coffee".In this 5th episode of the series, Chahan helps us understand where coffee research is headed in the future. They explored the low-hanging fruit coffee science research as well as the limitations it's experiencing. "Infused Coffees" was also a topic of discussion with some myths dispelled about testing.Connect with Chahan on LinkedIn here: https://www.linkedin.com/in/chahanyeretzian/

Q: How would you describe the 125-year journey of Roche in terms of the learning and mistakes?  [Hoffman] >Roche Holding AG is one of the oldest healthcare companies in the world >Made more goods than mistakes in the past 125 years Q: What do the next 125 years look like? [Hoffman] >The next 125 years look more challenging than the past 125 years >Front winds are stronger than they were in the past [Duschmale]  >Look back at 125 years to see how the company re-invented itself and stayed relevant, while the world around it changed dramatically Q: How do you think you are able to separate ownership and executing business efficiently? [Hoffman] >Fourth and fifth generation are in the business now >The idea that ownership is an active role takes a while to demonstrate and put into practice >Role of an owner is not the same as that of a manager >A manager needs to go into the detail of the presentation of strategy  >Owner, in a family ownership, needs to be able to dispose and organise things in the long term >Owner needs to have an understanding of the business, to be able to take the big strategy direction for the company  Q: What kind of strategic changes have you initiated after the pandemic, and what do they mean for India? [Hoffman] >Strategies didn't change only because the outside conditions changed  >Working on a strategy with one side on diagnostics, and the other side on pharmaceuticals >Diagnostics has demonstrated its value in dealing with public health during the pandemic >Operating principal of the company: Go where science takes you >Strategic vision is important, but at times we need to do a reality check Q: What are your thoughts on the role of India during Covid19? [Duschmalé]  >Vaccination programme that India managed to put together is stunning [Hoffmann]  >Want to see what a country of 1.4 billion people is spectacularly managing the vaccination programme

This is the 4th in a 5-part series with Chahan Yeretzian, Professor for Analytical Technologies, Bioanalytical Chemistry, and Diagnostics at Zurich University of Applied Sciences (ZHAW). In this series, Chahan and Lee explore "The Science of Coffee".In this 4th episode of the series, Chahan and Lee discuss how science handles the subjectivity of coffee taste objectively.Connect with Chahan on LinkedIn here: https://www.linkedin.com/in/chahanyeretzian/

This is the 3rd in a 5-part series with Chahan Yeretzian, Professor for Analytical Technologies, Bioanalytical Chemistry, and Diagnostics at Zurich University of Applied Sciences (ZHAW). In this series, Chahan and Lee explore "The Science of Coffee".In this 3rd episode of the series, Chahan helps us understand how science defines "Good Coffee". Super interesting conversation, folks!Connect with Chahan on LinkedIn here: https://www.linkedin.com/in/chahanyeretzian/

CLASSY IV: Exploring UV diagnostics of the interstellar medium in local high- z analogs at the dawn of the JWST era by Matilde Mingozzi et al. on Tuesday 20 September The COS Legacy Archive Spectroscopic SurveY (CLASSY) HST/COS treasury program provides the first high-resolution spectral catalogue of 45 local high-z analogues in the UV (1200-2000{AA}) to investigate their stellar and gas properties. We present a toolkit of UV interstellar medium (ISM) diagnostics, analyzing the main emission lines of CLASSY spectra (i.e., NIV]{lambda}{lambda}1483,87, CIV{lambda}{lambda}1548,51, HeII{lambda}1640, OIII]{lambda}{lambda}1661,6, SiIII]{lambda}{lambda}1883,92, CIII]{lambda}{lambda}1907,9). Specifically, we focus our investigation on providing accurate diagnostics for reddening, electron density and temperature, gas-phase metallicity and ionization parameter, taking into account the different ionization zones of the ISM. We calibrate our UV toolkit using well-known optical diagnostics, analyzing archival optical spectra for all the CLASSY targets. We find that UV density diagnostics estimate ne values that are ~1-2 dex higher (e.g., ne(CIII]{lambda}{lambda}1907,9)~10^4cm^{-3}) than those inferred from their optical counterparts (e.g., ne([SII]{lambda}{lambda}6717,31)~10^2cm^{-3}). Te derived from the hybrid ratio OIII]{lambda}1666/[OIII]{lambda}5007 proves to be a reliable Te diagnostic, with differences in 12+log(O/H) within ~+/-0.3dex. We also investigate the relation between the stellar and gas E(B-V), finding consistent values at high specific star formation rates, while at low sSFR we confirm an excess of dust attenuation in the gas. Finally, we investigate UV line ratios and equivalent widths to provide correlations with 12+log(O/H) and log(U), but note there are degeneracies between the two. With this suite of UV-based diagnostics, we illustrate the pivotal role CLASSY plays in understanding the chemical and physical properties of high-z systems that JWST can observe in the rest-frame UV. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.09047v1

CLASSY IV: Exploring UV diagnostics of the interstellar medium in local high- z analogs at the dawn of the JWST era by Matilde Mingozzi et al. on Tuesday 20 September The COS Legacy Archive Spectroscopic SurveY (CLASSY) HST/COS treasury program provides the first high-resolution spectral catalogue of 45 local high-z analogues in the UV (1200-2000{AA}) to investigate their stellar and gas properties. We present a toolkit of UV interstellar medium (ISM) diagnostics, analyzing the main emission lines of CLASSY spectra (i.e., NIV]{lambda}{lambda}1483,87, CIV{lambda}{lambda}1548,51, HeII{lambda}1640, OIII]{lambda}{lambda}1661,6, SiIII]{lambda}{lambda}1883,92, CIII]{lambda}{lambda}1907,9). Specifically, we focus our investigation on providing accurate diagnostics for reddening, electron density and temperature, gas-phase metallicity and ionization parameter, taking into account the different ionization zones of the ISM. We calibrate our UV toolkit using well-known optical diagnostics, analyzing archival optical spectra for all the CLASSY targets. We find that UV density diagnostics estimate ne values that are ~1-2 dex higher (e.g., ne(CIII]{lambda}{lambda}1907,9)~10^4cm^{-3}) than those inferred from their optical counterparts (e.g., ne([SII]{lambda}{lambda}6717,31)~10^2cm^{-3}). Te derived from the hybrid ratio OIII]{lambda}1666/[OIII]{lambda}5007 proves to be a reliable Te diagnostic, with differences in 12+log(O/H) within ~+/-0.3dex. We also investigate the relation between the stellar and gas E(B-V), finding consistent values at high specific star formation rates, while at low sSFR we confirm an excess of dust attenuation in the gas. Finally, we investigate UV line ratios and equivalent widths to provide correlations with 12+log(O/H) and log(U), but note there are degeneracies between the two. With this suite of UV-based diagnostics, we illustrate the pivotal role CLASSY plays in understanding the chemical and physical properties of high-z systems that JWST can observe in the rest-frame UV. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.09047v1

This is the 2nd in a 5-part series with Chahan Yeretzian, Professor for Analytical Technologies, Bioanalytical Chemistry, and Diagnostics at Zurich University of Applied Sciences (ZHAW). In this series, Chahan and Lee explore "The Science of Coffee".In this 2nd episode of the series, Chahan and Lee explore how coffee research is elevating specialty coffee as a profit-focused industry. Connect with Chahan on LinkedIn here: https://www.linkedin.com/in/chahanyeretzian/

Join us with our guest Dr. Robert Carman, Ph. D., Director of Microbiology at TECHLAB, Inc. Dr. Carman's research focuses on Clostridioides difficile (C. diff., C. difficile, CDI). Dr. Carman not only introduces us to the gut microbiome, but explains the details of the environment, the colonies of microorganisms, bacteria, viruses, protozoa, and fungi, that are present in the gastrointestinal tract

This is the first in a 5-part series with Chahan Yeretzian, Professor for Analytical Technologies, Bioanalytical Chemistry, and Diagnostics at Zurich University of Applied Sciences (ZHAW). In this series, Chahan and Lee explore "The Science of Coffee".In this first episode of the series, Chahan helps us understand how science is forging its way ahead into the specialty coffee industry and how it's elevating specialty coffee in the cup.Connect with Chahan on LinkedIn here: https://www.linkedin.com/in/chahanyeretzian/

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice's new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future, and how MCL is leading positive changes in the diagnostics industry.

Dr Dharmica Mistry is Director of Diagnostics and Industry Engagement at MTP Connect, a not-for-profit organisation focused on growing the MedTech, BioTech and pharmaceutical sectors. Prior to this she was the Co-Founder and Chief Scientist of BCAL Diagnostics, where the team's research discovered a potential new way to screen for breast cancer, which BCAL Diagnostics is working on developing into a scalable technology. Dharmica has also worked as Head of MedTech and BioTech at Cicada Innovations, a Sydney-based incubator with a focus on deep tech startups. In her conversation with guest host Will Tjo, Dharmica discusses the ways in which deep tech startups are distinct from other startups, as well as the role she believes government should play within the startup ecosystem. See full show notes: https://w2d1.com/dharmica-mistry

Sexually transmitted infections like chlamydial and gonorrhea are making a comeback, especially with younger demographics. Part of the problem is the stigma of examination and testing. These are not trivial infections, and can result in more complicated syndromes, which could include sterility or issues reproductive health. Early, discrete, confidential detection is key. Today's guest is Dr. Anna Dixon. She's the Chief Technology Officer of Binx Health. Her company has devised a lab-on-a-chip solution that provides fast and accurate diagnosis of specific infections in thirty minutes. Providing non-invasive, rapid and accurate, point-of-care detection can have profound roles in advancing patient care, as well as decreasing the incidence of disease in a population. 

Nelson Hendler, MD, MS CEO at Mensana Clinic Diagnostics, LLC Painvaliditytest.com

In this episode, Lena Chaihorsky, Co-Founder and VP of Payer Innovation at Alva10, and Michaela Miller, Practice Lead, Technology & Analytics at IQVIA, discuss value-based pricing in in vitro diagnostics. Featured Speakers: Lena Chaihorsky, Co-Founder and VP of Payer Innovation, Alva10Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA

This episode explores the role of at-home diagnostic testing in managing and preventing sexually transmitted diseases. More than 1 million sexually transmitted infections (STIs), which include syphilis, gonorrhea, chlamydia, HIV hepatitis, and other infections, are acquired every day worldwide. The majority of STIs are asymptomatic early detection that much more important to prevent the spread of these diseases. According to WHO, globally, 38.4 million people were living with HIV at the end of 2021. Science has advanced immensively to help treat and manage HIV. For over a decade, populations at risk can take preventative pills, which prevent HIV infections by over 99%. Unfortunately, access to this prophylaxis shouldn't be taken for granted. In the US, prevention is supposed to be covered by insurance under the Affordable Care Act. However, in September, a district court ruling in Texax potentially endangered this access. A Christian-owned company argued against the Affordable Care Act's requirement that insurers and employers offer plans that cover PrEP for free. The argument was that this statutory provision “forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use.” The company won the case, and the ruling opened up concerns about what this will mean for future efforts and coverage for preventative health measures.  In this - which was published before the Texas Court ruling -, you will hear from  Emma Rayer is the Head of Strategic Partnerships for Ash Wellness, a remote diagnostics solution. Ash Wellness supports traditional healthcare systems, universities, public health initiatives, and digital health companies in giving patients access to at-home sample collection kits that are then sent and analyzed in laboratories.  Emma talked about the differences in the attitude towards testing for STIs in South Africa, where she grew up in and the US, where she lives now. She also explained how the Ash platform works, how is at-home diagnostics market evolving, and more.  www.facesofdigitalhealth.com Recap of this episode: www.facesofdigitalhealth.com/blog/std-prevention-through-platform Leave a rating or a review: lovethepodcast.com/facesofdigitalhealth Thank you! :) !Subscribe to the monthly newsletter! - https://fodh.substack.com/

Musculoskeletal (MSK) pain and osteoarthritis are clinically common in general practice, but with the new draft NICE guideline on osteoarthritis (published in April 2022) recommending a move away from pharmacological treatments and instead promoting self-management, some GPs have been left wondering how best to manage MSK pain going forwards . In this week's episode, Dr. Imran Sajid talks to us about the importance of educating patients on what arthritis really is – moving away from the term “wear and tear” – and of taking a thorough history of a patient's pain journey in consultations. He also gives practical advice on how we might approach non-pharmacological management of MSK pain with our patients. Our guest: Imran Sajid is a GP with a special interest in MSK medicine. He is the clinical lead in MSK & Diagnostics for NHS North West London, an adjunct lecturer in Health Policy at the University of Global Health Equity, as well as being a qualified personal trainer. Further reading: ‘Osteoarthritis: assessment and management, draft for consultation, April 2022'. NICE. 2022. https://www.nice.org.uk/guidance/gid-ng10127/documents/draft-guideline ‘The tear, flare, and repair model of osteoarthritis'. BMJ 2022;377:o1028. https://www.bmj.com/content/377/bmj.o1028

Heart failure is, without a doubt, one of the more complex topics that you will encounter in primary care. Two types, four stages, four classes, evolving guidelines for treatment, and a host of medications – it's a lot to wrap your head around. Especially in a 15-minute visit. Let's talk about the core concepts of heart failure and increase your confidence. We'll cover:✅ The two types of heart failure, and how the different types impact the approach to treatment✅ Diagnostics – which labs, which tests, and the crucial role of ejection fraction in heart failure✅ The questions you don't want to forget to ask the patient✅ Medications used to treat heart failure✅ What to look for in the chart BEFORE the first visitLike so many other things with primary care, managing heart failure gets less stressful with time. But until then, having a strategy will increase your efficiency in the visit, your confidence on the subject, and give you clarity about co-managing with cardiology. Heart Failure Guidelines 2022-----------------------Don't forget to grab your free Ultimate Resource Guide for the New NPSign up for the Lab Interpretation Crash Course Grab your copy of the Digital NP Binder------------------------Come follow along for even more tips and inspiration:Instagram: https://instagram.com/realworldnpFacebook: https://facebook.com/realworldnp______________________________Please note: This video is intended only for medical providers and students learning to be medical providers. While anyone is welcome to view, for legal and safety reasons, we are unable to diagnose, treat, or answer medical questions for individuals through this channel. We always refer individuals back to their primary care providers for medical care.If you're a medical provider or student and have specific patient cases you have questions about, I cannot answer those here but would love to help you inside our mentorship program! Join the waitlist at https://www.realworldnp.com/mentoring. _______________________________© 2022 Real World NP. For educational and informational purposes only, see realworldnp.com/disclaimer for full details. Hosted on Acast. See acast.com/privacy for more information.

Can Molecular Ratios be used as Diagnostics of AGN and Starburst activity? The Case of NGC 1068 by J. Butterworth et al. on Tuesday 13 September Molecular line ratios, such as HCN(1-0)/HCO$^+$(1-0) and HCN(4-3)/CS(7-6) are routinely used to identify AGN activity in galaxies. Such ratios are however hard to interpret as they are highly dependent on the physics and energetics of the gas and hence can seldom be used a as a unique unambiguous diagnostic. We use the composite galaxy NGC 1068 as a "laboratory", to investigate whether molecular line ratios between HCN, HCO$^+$ and CS are useful tracers of AGN-dominated gas and determine the origin of the differences in such ratios across different types of gas. Such determination will allow a more rigorous use of such ratios. We first empirically examine the aforementioned ratios at different angular resolutions to quantify correlations. We then use LTE and non-LTE analyses coupled with Markov Chain Monte Carlo (MCMC) sampling in order to determine the origin of the underlying differences in ratios. We propose that at high spatial resolution (< 50 pc) the HCN(4-3)/CS(2-1) is a reliable tracer of AGN activity. Finally we find that the variations in ratios are not a consequence of different densities or temperature but of different fractional abundances yielding to the important result that it is essential to consider the what chemical processes are at play when drawing conclusions from radiative transfer calculations. Upon analysis at varying spatial scales previous proposed as well as a new molecular line ratio have been shown to have varying levels of consistency. We have also determined from investigation of radiative transfer modelling of our data that it is essential to consider the chemistry of the species when reaching conclusions from radiative transfer calculations. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.05928v1

In this new series, Miranda will highlight one of Street Parking's 40+ Extra Programs. Episode will cover WHO this program is for, WHAT it is, WHY we created it, and HOW to use it and add it in to the daily programming. She will also answer questions from the Street Parking Members Facebook group. In this episode we talk “Diagnostics".  16 Workouts. 4 Levels for wach - with specific required movements, weights, and a time to beat. Test and re-test these to guage your overall fitness.

I had a call with my Buyers agent a few weeks ago.He made a passing comment that probably wasn't significant to him.But… did keep me up that night.“If you are thinking of buying another property, move quickly! As you won't get the lending you want from the bank if you wait too long.”I pulled him up and asked him to explain.As I thought that I was in a strong lending position.My balance sheet and business profits are solid in my eyes.Even better than last year.“Interest rates plus inflation,” he said the reason was.He then went on to school me on how things are changing when it comes to borrowing.I'll summarise his points below.*** Please note the below points were specific to my situation ***You need to speak to a lending specialist to understand the impacts on your own borrowing capacity.Inflation:In the bank's eyes, your cost of living has gone up due to inflation.Even if you haven't changed the way you live, the cost of living for you has gone up, and you are seen as less capable of servicing a loan because of it.Interest rates:For every 1% the interest rate goes up, my borrowing capacity will go down 9%This compounds across all your borrowing, not just the new borrowing you are contemplating.For someone with a portfolio of my size, a 1% rise can be a 20%-25% decrease in borrowing power.Pair these up, and my borrowing capacity is being constricted more and more each month!This is what was keeping me up at night.I was severely underestimating the impacts of rate rises and inflation on overall borrowing.So a question I kept coming back to:“Do I make a move now or wait?”A tough question for anyone, especially with all that is going on in the world…Anyhow, To help others understand this topic more deeply, I have brought Aaron Whybrow on the podcast.Our resident mortgage broker and lending specialist for business owners.He was gracious enough to walk us through a practical example of how lending works when rates are going up, and inflation is on a tear.If you want to understand how borrowing works, this is the episode for you.Episode Highlights:00:00 Welcome to Full Stack Business Owner02:26 Learn about Aaron and his mortgage broking firm03:25 How interest rate rise affects borrowing power07:30 Different ways lenders assess your borrowing power12:27 The impact of debt and loss in your borrowing capacity16:43 Increasing income to increase borrowing power20:07 Assessing household expenditures23:26 The right time to borrow money27:05 How people are keeping up with inflation and high interest rates32:54 Outpacing your business incomeIf you enjoyed this episode, be sure to subscribe, tune in and share this podcast!Resources:○ Full Stack Business Owner website: https://www.fullstackbusinessowner.com/○ Full Stack Business Owner partners: https://www.fullstackbusinessowner.com/partners/About the Guest: Aaron Whybrow is the founder of Diagnostics and Finance, a Financial Broking and Personal Risk Insurance Business. Diagnostics & Finance (ARW Financial Services Pty Ltd) is a Credit Representative 425540 of Finsure Finance & Insurance ACL 384704. He is known as the ‘bagpiping mortgage broker', who prides himself on having no ‘flats' in his career. He blends his experiences as a former intensive care unit nurse and medical sales rep to provide the best outcomes for his clients. To connect with Aaron and his team of mortgage professionals, head over to https://www.fullstackbusinessowner.com/partners/diagnostics-and-finance/ Subscribe: ○ Subscribe on Youtube: https://www.youtube.com/channel/UCwTrdJ5udIvx44PgEAlHgmw○ Subscribe on Apple Podcast: https://podcasts.apple.com/au/podcast/full-stack-business-owner/id1607453342Connect with Full Stack Business Owner: ○ Join the Full Stack Business Owner Community: https://www.facebook.com/fullstackbusinessowner/○ Follow us on Facebook: https://www.facebook.com/fullstackbusinessowner/○ Follow us on Instagram: https://www.instagram.com/fullstackbusinessowner/○ Send your enquiries or drop by to say hello: grant@fullstackbusinessowner.comDISCLAIMER:All information we share is NOT financial or investment advice and is purely intended for entertainment and educational purposes only. Always seek professional advice before acting on any financial decision.See omnystudio.com/listener for privacy information.

Leyla Soleymani is Canada's Research Chair in Miniaturized Biomedical Devices. Her passion for the miniature world of nanotech and her commitment to collaboration have led her and her colleagues at McMaster University to inventions ranging from rapid tests that use pig saliva to disease detection to a plastic wrap that repels pathogens like rain drops off a lotus leaf.

Deciphex, a leading provider of Digital Pathology software and services, has announced the launch of their Diagnexia service in the United States. Remote expert subspecialty pathology on demand Diagnexia virtual pathology service provides on-demand access to remote subspecialty experts for pathology consult services on an advanced collaborative platform. This provides significant support to overworked and under-staffed pathology departments without experts available on every subspeciality. The platform connects laboratories to an international network of subspeciality pathologists, who can provide their expertise on clinical cases, while vastly reducing turnaround times and ensuring delivery of the highest quality of patient care. Busy academic teams within hospital networks will also benefit from having extra experts available on demand to help balance workloads. Eligible retiring pathologists may join the Diagnexia network and work remotely part-time. Global subspecialty expertise when needed Pathology is heading for a crunch point due to increasing volumes, increasing complexity and flat to declining pathologist numbers. Pathologists are in high demand worldwide, and their number is predicted to significantly decrease over the next ten years. Diagnexia delivers a global network of subspecialty pathology experts to ease pathology bottlenecks, accelerate diagnoses and enhance patient outcomes. Accepted and proven internationally Diagnexia is already a leading international service and is used by Healthcare Providers internationally including the UK's National Health Service (NHS). Steve Blunden, Cellular and Anatomical Pathology Operations Manager at University Hospitals Plymouth NHS Trust states: “We have recently started a partnership with Diagnexia both as a supplier of technical services to them and a user of their diagnostic service. Digital Pathology will play a key role in revolutionising this key area of healthcare provision and equip leading Pathologists with the capabilities to deliver their skills at scale.” Donal O'Shea, Chief Executive Officer of Deciphex, adds “The US launch of Diagnexia is an important milestone for the business in its ambition to use Digital Pathology and AI to provide easy access to the world's leading pathologists. Chronic issues in Pathology such as burgeoning patient wait times, recruitment, demand for expertise and diagnostic complexity has necessitated a new approach to improving patient care.” “Even well-resourced healthcare systems with relatively ‘High-Pathologist Density' have a chronic lack of capacity leading to backlogs, delayed diagnosis, care and patient outcomes. The ability to alleviate these difficulties with seamless, state of the art technology is game-changing and ultimately of huge benefit to patients, health services, and pathology labs.” he adds. See more stories here.

Radiative processes as diagnostics of cometary atmospheres by D. Bodewits et al. on Wednesday 07 September In this chapter, we provide a review of radiative processes in cometary atmospheres spanning a broad range of wavelengths, from radio to X-rays. We focus on spectral modeling, observational opportunities, and anticipated challenges in the interpretation of new observations, based on our current understanding of the atomic and molecular processes occurring in the atmospheres of small, icy bodies. Close to the surface, comets possess a thermalized atmosphere that traces the irregular shape of the nucleus. Gravity is too low to retain the gas, which flows out to form a large, collisionless exosphere (coma) that interacts with the heliospheric radiation environment. As such, cometary comae represent conditions that are familiar in the context of planetary atmosphere studies. However, the outer comae are tenuous, with densities lower than those found in vacuum chambers on Earth. Comets, therefore, provide us with unique natural laboratories that can be understood using state-of-the-art theoretical treatments of the relevant microphysical processes. Radiative processes offer direct diagnostics of the local physical conditions, as well as the macroscopic coma properties.These can be used to improve our understanding of comets and other astrophysical environments such as icy moons and the interstellar medium. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.02616v1

Radiative processes as diagnostics of cometary atmospheres by D. Bodewits et al. on Wednesday 07 September In this chapter, we provide a review of radiative processes in cometary atmospheres spanning a broad range of wavelengths, from radio to X-rays. We focus on spectral modeling, observational opportunities, and anticipated challenges in the interpretation of new observations, based on our current understanding of the atomic and molecular processes occurring in the atmospheres of small, icy bodies. Close to the surface, comets possess a thermalized atmosphere that traces the irregular shape of the nucleus. Gravity is too low to retain the gas, which flows out to form a large, collisionless exosphere (coma) that interacts with the heliospheric radiation environment. As such, cometary comae represent conditions that are familiar in the context of planetary atmosphere studies. However, the outer comae are tenuous, with densities lower than those found in vacuum chambers on Earth. Comets, therefore, provide us with unique natural laboratories that can be understood using state-of-the-art theoretical treatments of the relevant microphysical processes. Radiative processes offer direct diagnostics of the local physical conditions, as well as the macroscopic coma properties.These can be used to improve our understanding of comets and other astrophysical environments such as icy moons and the interstellar medium. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.02616v1

Radiative processes as diagnostics of cometary atmospheres by D. Bodewits et al. on Wednesday 07 September In this chapter, we provide a review of radiative processes in cometary atmospheres spanning a broad range of wavelengths, from radio to X-rays. We focus on spectral modeling, observational opportunities, and anticipated challenges in the interpretation of new observations, based on our current understanding of the atomic and molecular processes occurring in the atmospheres of small, icy bodies. Close to the surface, comets possess a thermalized atmosphere that traces the irregular shape of the nucleus. Gravity is too low to retain the gas, which flows out to form a large, collisionless exosphere (coma) that interacts with the heliospheric radiation environment. As such, cometary comae represent conditions that are familiar in the context of planetary atmosphere studies. However, the outer comae are tenuous, with densities lower than those found in vacuum chambers on Earth. Comets, therefore, provide us with unique natural laboratories that can be understood using state-of-the-art theoretical treatments of the relevant microphysical processes. Radiative processes offer direct diagnostics of the local physical conditions, as well as the macroscopic coma properties.These can be used to improve our understanding of comets and other astrophysical environments such as icy moons and the interstellar medium. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2209.02616v1

In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team's mission of accessibility. 

With a unique multi-target approach, what it considers the world's best adjuvant, and a host of learnings from the successes and failures of COVID-19 vaccine efforts, Longhorn Therapeutics is gaining steam in its pursuit of a universal influenza vaccine. On this episode of the Business of Biotech, Longhorn Vaccines & Diagnostics Co-Founder and President Jeff Fischer gives us a transparent look at the science and the partnerships that are giving him cause to believe his company will succeed where so many have failed.

CME credits: 1.00 Valid until: 31-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/improved-outcomes-in-mcrpc-with-psma-directed-diagnostics-and-therapies/13789/ Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT). In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

CME credits: 1.00 Valid until: 31-08-2023 Claim your CME credit at https://reachmd.com/programs/cme/improved-outcomes-in-mcrpc-with-psma-directed-diagnostics-and-therapies/13789/ Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT). In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

Host: Ayse Tuba Kendi, MD Guest: A. Oliver Sartor, MD Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT). In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

In this episode, David and Lucas sit down with Brandon Dills, the owner of Jarhead Diagnostics and Small Town Automotive Technologies in Lexington, NC.Brandon recently found himself embroiled in some online drama. He discusses what set it off, how he reacted, and the lessons, if any, learned. Are you spending your nights at the shop or worrying about the shop? Get the numbers you need to see what's going on with each tech and each profit center, thanks to advanced analytics. Get Shop-Ware.com and get some sleep.Click Here: Get Shop-Ware.comAfter going to GetShopWare.com, head over to https://bit.ly/ASTE-2022 to register for ASTE! Support the show

You know CCTV as a useful police tool - how else did they ever catch the bad guys?! Now imagine eliminating your drain-blocking suspect the same way. Not as exciting but the same principle! Call Sewer Surgeon Pty Ltd (1300-734-677). Check them out at https://sewersurgeon.com.au/cctv-camera-pipe-inspections (https://sewersurgeon.com.au/cctv-camera-pipe-inspections)

In this episode Chris Johnson covers his top 5 metrics for your health and how to improve them. Hosted by Matt Johnson. Learn more, download free resources, and more at ontargetliving.com

On today's episode of The Thoughtful Entrepreneur, we are so excited to speak with CEO and cofounder of Ash, David Stein! Ash is an at home diagnostic testing platform. They partner with providers, hospital systems, public health departments, and universities to turn on self testing programs through at home testing kits.  He discusses the future of Ash and expresses them as a technology company first. They started in diagnostics as a gateway for individuals into health care to do a test and understand where they are on a spectrum of diseases and disease states. He discusses the changes in health care since Covid-19 and how health care is adapting to home health care. David shares how he hopes that his platform can help people access healthcare in places that are most convenient and most comfortable for them. This makes it a lot more accessible and inclusive and ultimately the hope is that the long term health outcomes are better because people are actually able to receive the help they need. Don't forget to listen to our next episode, where we recap all the great insights that David Stein offered!  Key Points from the Episode: Power at home testing programs creating more accessibility to healthcare Adapting from B2C to B2B with home diagnostic testing platforms  Changes in traditional health care and the adaption to home health care  Impact of greater accessibility to healthcare through providing at home health care services About David Stein: David Stein is the CEO of Ash Wellness, a B2B at-home diagnostic company launching remote care services for healthcare organizations and D2C businesses. Ash Wellness offers white-lable operations management, testing via a CLIA/CAP certified lab network, kitting and fulfillment, and modern technology infrastructure. In his role, David is responsible for mission vision, strategy oversight, fundraising, and corporate development. He is a graduate of the Cornell Tech MBA program Links Mentioned in this Episode:  Want to learn more? Check out Ash's website at https://www.poweredbyash.com/ (https://www.poweredbyash.com/)  Check out David Stein on LinkedIn at https://www.linkedin.com/in/davidstein100/ (https://www.linkedin.com/in/davidstein100/)  Don't forget to subscribe to The Thoughtful Entrepreneur and thank you for listening. Tune in next time! More from UpMyInfluence: ️  We are actively booking guests for our The Thoughtful Entrepreneur.https://upmyinfluence.com/guest ( Schedule HERE). Are you a 6-figure consultant? I've got high-level intros for you.https://upmyinfluence.com/b2b ( Learn more here). What is your #1 Lead Generation BLOCKER? http://upmyinfluence.com/quiz (Take my free quiz here).

Erez Naaman is the CTO and co-founder of Scopio Labs, a company specializing in hematology that's revolutionizing diagnostics through artificial intelligence and full-field morphology.In this episode, we discuss the topic of digital transformation in diagnostics, with a special focus on the impact and the future potential of artificial intelligence. We talk more generally about laboratory medicine and the role of diagnostics there before diving deeper into the obvious impacts of COVID and the accelerated digitalization (not to be confused with digitization, which Erez also points out and explains).Links & mentions:scopiolabs.com

This week, we are sharing some tips and tricks to gear up for the new school year. We'll discuss reminders, considerations, and EdTech tools you might use as you get started with your planning.  If you like what you hear, we would love it if you could share this episode with a colleague or friend. And make sure you subscribe so that you don't miss out on any new content! And consider supporting the show by buying us a coffee or two!We would love to hear from you – leave a comment on our website OR check out our FLIPGRID!Featured Content**For detailed show notes, please visit our website at https://edugals.com/98**Start with big-picture or long-range planning:Prioritize your ambitions and goals - rein in your wild ideas!Long-range planning will help make the day-to-day planning easierThink about what your summative assessments will beThe minutia of the daily planning will get done - it's ok to not have that ready yet because you need to get to know your students firstMastery-based learning - different way of thinking which gives you more flexibility in planningGrowing pains will happen - expect them if you are trying something new!EdTech Tools we recommend:Screencasting tools - Screencastify, Loom, Screencast-o-matic, Explain Everything, OBS Studio (stick to one only for students)Loom for EducatorsCheck for privacy/data and board/district policiesGoogle Slides - create HyperDocs for mastery-based learning (better than docs)Learning Management System (Google Classroom, Brightspace, Canvas, etc) - organization, consistent naming/numbering systems, personalization, minimize navigationGoogle Assignments in LMS for student submissionsCommunity Building:Super important over the first two weeks of schoolHands-on learning in small, randomized groupings (inquiry, design thinking, etc)Diagnostics to figure out starting pointsConsider skills units at the beginning of the semesterHelp new students learn about their school community (tours)Use simple icebreaker activities to start off group work (this or that, would you rather, two truths and a lie, etc) - model this first as a teacherColleague relationships matter too! Informal is better than forced icebreakersSelf-Care:Establish your routines now, prioritize yourself and your goalsFigure out what works for you, self-care looks different for everyoneAdd habits to your to-do list (Todoist is great!)Support the show

Eric Doherty is President of PERSOWN, the company striving to make a lifesaving impact by delivering accurate, rapid and affordable diagnostics to the point of care anywhere in the world.In this episode of The Health Pulse, Doherty joins host Alex Maiersperger to discuss disparities in global health care and how access to high-quality, low-cost diagnostics can help close the gap. Doherty shares the shocking statistic that there are 0.23 doctors per 10,000 people in the world's poorest countries. What's more, diagnostic errors account for the deaths of 7 million children per year worldwide.PERSOWN addresses devastating global health care access disparities with high-quality, affordable diagnostics with results in under two minutes. The company is working on assays for various applications, including COVID-19, tuberculosis, sepsis, breast cancer, Alzheimer's disease and concussions. Doherty shares an inspiring vision of the role of technology in health care innovation and the importance of personal ownership of health care data.

Breast cancer screening can help find breast cancer early when the chances of survival are highest. In this episode, we are going to learn more about Komen's Screening & Diagnostics Program, which provides no-cost breast cancer screening and diagnostic services for people of all ages and genders who meet income guidelines in select cities. I am excited to be joined by Jade Gibson, a patient navigator at Komen, and Morgan Barnes, a Wellness Program Coordinator at the Center for Black Women's Wellness in Atlanta, to learn more about the Screening & Diagnostics Program. Welcome to the show, Jade and Morgan!

Bumper to Bumper Radio, the car guys on KTAR, 92.3 FM in Phoenix, AZ, broadcast every Saturday from 11:00 am to noon. On this show, Matt ...

Beyond Right Answer: Math Tasks that Foster Agency and Identity Date: August 9, 2022 Getting the right answer doesn't always lead to deeper learning. Join us for an interactive session on how to create an atmosphere that promotes student thinking, problem-solving, & growth mindset by engaging students in culturally rich mathematical investigations. Leave with some great "wonders" to pose in your classroom & facilitation strategies. Presenters: Twana Young Recommended Grade Level: K-6 Hosted by: Jessica Bogie Watch the full presentation at: https://www.bigmarker.com/GlobalMathDept/Data-Rich-with-Diagnostics

In today's episode, we are joined by Damien P. Alagia, MD, MS, MBA, Chief Clinical Officer of Health Systems at Quest Diagnostics, to discuss the role of diagnostic testing in patient care. Tune in to learn more about the integration of diagnostic testing, common challenges health systems face when expanding their diagnostics strategy across the care continuum and how success is defined.This episode is sponsored by Quest Diagnostics.

Operational downtime costs thousands of dollars and creates unnecessary headaches. To reduce downtime stress and expand asset control, we're diving into the benefits of SOTI's new Xsight Platform – the MDM solution set to maximize asset visibility and empower remote troubleshooting with real-time support. Learn how to transform operations with SOTI & Heartland, and stay ahead of complex integration and supply chain challenges.-------------------------------------------------------------------------------------------------------------------Shash Anand is SOTI's Vice President of Product Strategy and has built strategicalliances and support systems. Equipped with an academic foundation of an MBA in Computer Engineering and years of professional experience, Shash has cultivated a reputation for being a passionate, supportive leader, eager to tackle business problems and dive into the smallest details.    Todd Greenwald is our OpTech Insights host and Heartland's dedicated automation specialist with over 25 years of experience. As Heartland's President, Todd has always been passionate about empowering solutions with adaptable technologies, redefining innovation with fervent eagerness, and improving communities with quality service and expertise.  Want to learn more about Heartland and SOTI's partnership? Reach out to our teams at https://heartland-usa.com/contact-us/

Like the Beyond the Wrench podcast? Be sure to follow & rate us — whether on Apple Podcasts, Google Podcast, YouTube, or wherever you get your podcasts!In this week's episode of Beyond the Wrench, Joel Adcock, Director of Business Development, Precision Diagnostics joins us to discuss finding quality diagnostic technicians, how he keeps up with the changes in technology, and the process behind being a mobile technician. Resources: Learn more about WrenchWay Shop TalkDownload the free WrenchWay app in the App Store or on Google Play:App Store: https://apps.apple.com/us/app/id1534587616Google Play: https://play.google.com/store/apps/details?id=com.wrenchway.insidersAbout Our Host:Jay GoninenCo-Founder & President, WrenchWayjayg@wrenchway.com | 608.716.2122About Our Guest:Joel AdcockDirector of Business Development, Precision Diagnosticsjoel.adcock@precisiondiagnosticsco.comSponsor:Fullbay: Fullbay is an industry-leading software solution for Heavy-Duty Repair shops. Their platform enables shops to receive repair requests, invoice customers, and everything in between. With Fullbay, owners and employees get into the shop, get their work done, and get back to their friends and families. To learn more about Fullbay visit fullbay.com/wrenchway.

It's obvious really, that you can't treat your way out of a pandemic without the right diagnostics to tell you who is infected, and with which variant of virus or bacterium - and in this episode Ben chats with two leading experts on how laboratory and point of care diagnostics form the essential backbone to any effective infectious disease public health program. Sponsored by Roche Molecular. Ben is joined by Dr. Tamar Tchelidze, and Dr. Ben La Brot, physicians from Roche Molecular Systems Inc, both with deep frontline expertise in combating pandemics. https://www.who.int https://www.unaids.org/en https://www.cdc.gov https://diagnostics.roche.com https://www.ashotinthearmpodcast.com #infectiousdisease #pandemics #covid #HIV #AIDS #tb #malaria #pandemicsresponse #diagnostics #laboratory #treatment #testing #prevention #screening #PrEP #injectables

Dr. Natalie Marks joins the podcast to discuss how invoice bundling (the bundling together of diagnostics, specifically) can help inexperienced doctors develop, leverage technicians more effectively, increase profitability, make cases simpler for practitioners, and speed up our treatment of sick pets. She and Dr. Andy Roark also discuss advice for getting veterinarians on board with diagnostic bundling, what bundles make the most sense, and what common mistakes to avoid when introducing the concept to your clinic. LINKS Veterinary Angel Network (VANE): https://www.vane.vet/ Dr. Natalie Marks' Website: https://marksdvmconsulting.com/ LinkedIn: https://www.linkedin.com/in/natalie-marks-dvm-cvj-54b0429a/ Dr. Andy Roark Exam Room Communication Tool Box Course: https://drandyroark.com/store/ What's on my Scrubs?! Card Game: https://drandyroark.com/training-tools/ Dr. Andy Roark Swag: drandyroark.com/shop All Links: linktr.ee/DrAndyRoark ABOUT OUR GUEST: Dr. Natalie Marks obtained her bachelor's degree with High Honors in Animal Science from the University of Illinois in 1998, and then proceeded to obtain a Masters in Veterinary Medicine and Doctorate of Veterinary Medicine degree with High Honors from the University of Illinois College of Veterinary Medicine. She became a Certified Veterinary Journalist in 2018. She has been a veterinarian at Blum Animal Hospital since 2006, co-owner until 2018 and current associate. Prior to 2006, Dr. Marks worked at Allatoona Animal Hospital just north of Atlanta, GA. Her media experience began in print when she created several monthly veterinary columns in multiple community magazines and was a frequent guest speaker for the German Shepherd and Bernese Mountain Dog clubs of Atlanta. Dr. Marks has received many prestigious awards in her career. She was awarded the Dr. Erwin Small First Decade Award, presented to a veterinarian that has contributed the most to organized veterinary medicine in his or her first decade of practice. In 2012, Dr. Marks was awarded Petplan's nationally-recognized Veterinarian of the Year. In 2015, she was awarded America's Favorite Veterinarian by the American Veterinary Medical Foundation. And, most recently in 2017, she was awarded Nobivac's Veterinarian of the Year for her work on canine Influenza. Dr. Marks is a regular columnist in Today's Veterinary Business, Healthy Pet magazine, and Pet Vet, and has been published in Veterinary Medicine magazine, DVM magazine, Dogster, and Vetted. She is on the Advisory Board for Health Magazine and also was the host of numerous veterinary broadcasts for the Viticus Group (formerly WVC). She is a desired national and international lecturer for many of the same companies at VMX, WVC, AVMA and regional conferences, and most recently was a featured speaker at Ceva Sweden's Derm Day and the Royal Canin Global Symposium. Dr. Marks finds the ideal combination of teaching/mentoring and improving the emotional health of pets in the Fear Free movement. She sat on the Fear Free Executive Council and is a national educator helping other private practitioners develop these techniques. She also led her practice to become the 7th nationally and first practice in Illinois to become a Fear Free Certified Hospital. She is an Elite Fear Free Certified Professional. Finally, Dr. Marks is a serial entrepreneur, angel investor and consultant, and one of the newer members of VANE, the Veterinary Angel Network.

Digital Education Conference 2022 in Oct 7 & 8 2022: https://cmecatalog.hms.harvard.edu/digital-educationWhat does each diagnostic test tell you? How do you interpret urine osmolality, urine sodium, or urine urea? What studies can be used to better assess response to treatment? How can uric acid be utilized as a diagnostic tool? What is the interplay between ADH and UOsm?Show notes, Transcript and References: https://www.coreimpodcast.com/2021/02/10/5-pearls-on-hyponatremia-episode-1/ACP CME: https://www.acponline.org/cme-moc/cme/internal-medicine-podcasts/core-imTags: urine studies, SIADH, Core IM, IMCore, antidiuretic hormone, hospital medicine, family medicine, nephrology

Our How-To Series rolls on. The boys tackle crank no-start this week. It's something many of us diesel owners have experienced, but how do you diagnose this? Paul and Chris have got that question covered this week!

In this episode, Autistic psychology practitioner Matt Lowry helps us dive into what a strengths-based diagnostics process looks like for autism, and the incredible difference this can make. We also explore what parents and other professionals should look for to find a neurodiversity-affirming evaluator when making a referral. And Matt reads us a story that he wrote called The Legend of Autistica, which is his poignant, hilarious, and insightful origin story of the Autistic people.

Summary:Testing the population is a vital step in the pursuit of disease control. During the COVID-19 pandemic, when the biotech industry was challenged to rapidly adapt and produce safe, effective testing at an almost unimaginable scale, businesses were forced to adapt and re-think the way diagnostic tests are designed, distributed, and safely conducted in order to keep up with demand. Today's guest is Jeff Fischer. Jeff is the co-founder and president of Longhorn Vaccines & Diagnostics LLC, an industry leading biotechnology company that has been on the frontlines of the battle with COVID-19. From 2007 to 2017, Jeff served as CFO of Longhorn. Jeff has previous experience in the biotech industry as an executive VP and CFO, and he is also a former infantry officer in the United States Marine Corps.In this episode, Jeff and I discuss Longhorn's innovative FDA-approved PrimeStore Molecular Transport Medium -- a product that has changed the way viruses are tested, how seeking FDA approval helped with mass rollout in a time of crisis, and how Longhorn found an unusual solution to a shortage of essential supplies. Highlights: Jeff discusses his motivation to start a company focused on diagnostic tools to address what he saw as a coming influenza pandemic (03:00) How life in the Marine Corps influenced Jeff's understanding of the world and his work (04:03) What is PrimeStore Molecular Transport Medium? (05:35) How Longhorn adapted to increased demand during the pandemic (10:10) How the Coca-Cola Bottling Group became the solution to test tube supply chain issues during the pandemic (13:43) Jeff discusses Longhorn's market opportunity and long term avenues for growth (15:47) Jeff explains the agility and independence afforded to Longhorn by not being a public company (17:29) What is the concept of "one health," and how will it change the way we think about the health of humans and the planet (19:10) Is a universal influenza vaccine just around the corner? (21:24) Links:ICR TwitterICR LinkedInICR WebsiteJeff Fischer LinkedInLonghorn LinkedInLonghorn WebsiteFeedback:If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, elizabeth@lowerstreet.co.

Today we flash back to when Charlamagne gave "Donkey of the Day" to Gravity Diagnostics in Covington, for throwing a surprise birthday party for their employee that did not want to celebrate. See omnystudio.com/listener for privacy information.